Vistagen Therapeutics
(NASDAQ) VTGN
Vistagen Therapeutics Financials at a Glance
Market Cap
$22.64M
Revenue (TTM)
$790.00K
Net Income (TTM)
$67.05M
EPS (TTM)
$0.00
P/E Ratio
-0.36
Dividend
$0.00
Beta (Volatility)
2.18 (High)
Dividend
$0.00
Beta (Volatility)
2.18 (High)
Price
$0.61
Volume
816,980
Open
$0.60
Price
$0.61
Volume
816,980
Open
$0.60
Previous Close
$0.60
Daily Range
$0.59 - $0.63
52-Week Range
$0.43 - $5.14
Dividend
$0.00
Beta (Volatility)
2.18 (High)
Price
$0.61
Volume
816,980
Open
$0.60
Previous Close
$0.60
Daily Range
$0.59 - $0.63
52-Week Range
$0.43 - $5.14
VTGN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vistagen Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
59
CEO
Shawn K. Singh
Website
www.vistagen.comHeadquarters
South San Francisco, CA 94080, US
VTGN Financials
Key Financial Metrics (TTM)
Gross Margin
55%
Operating Margin
-88%
Net Income Margin
-85%
Return on Equity
0%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-2.78%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$22.64M
Shares Outstanding
39.62M
Volume
816.98K
Short Interest
0.00%
Avg. Volume
929.38K
Financials (TTM)
Gross Profit
$486.00K
Operating Income
$55.97M
EBITDA
$55.34M
Operating Cash Flow
$42.10M
Capital Expenditure
$191.00K
Free Cash Flow
$42.29M
Cash & ST Invst.
$80.48M
Total Debt
$1.51M
Vistagen Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$303.00K
+29.5%
Gross Profit
$114.00K
-51.3%
Gross Margin
37.62%
N/A
Market Cap
$22.64M
N/A
Market Cap/Employee
$471.73K
N/A
Employees
48
N/A
Net Income
$18.90M
-34.1%
EBITDA
$19.36M
-29.4%
Quarterly Fundamentals
Net Cash
$60.34M
-30.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$431.00K
-61.2%
Short Term Debt
$996.00K
+65.2%
Return on Assets
-1.03%
N/A
Return on Invested Capital
-1.36%
N/A
Free Cash Flow
$17.57M
-70.9%
Operating Cash Flow
$17.63M
-71.5%